OOIR: Observatory of International Research

Papers

(The H4-Index of Epilepsy & Behavior is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
The global burden of epilepsy report: Implications for low- and middle-income countries	89
The Epileptic Heart: Concept and clinical evidence	82
Epilepsy and COVID-19: Associations and important considerations	74
Meta-analysis of EEG findings in patients with COVID-19	66
Fenfluramine acts as a positive modulator of sigma-1 receptors	63
Terminology for psychogenic nonepileptic seizures: Making the case for “functional seizures”	61
Seizure as the presenting symptom of COVID-19: A retrospective case series	58
The effect of COVID-19 pandemic on seizure control and self-reported stress on patient with epilepsy	55
Pharmacodynamic interactions of antiepileptic drugs: From bench to clinical practice	48
Underutilization of epilepsy surgery: Part I: A scoping review of barriers	47
Epilepsy self-management during a pandemic: Experiences of people with epilepsy	47
Telemedicine and the challenge of epilepsy management at the time of COVID-19 pandemic	46
Access to healthcare and prevalence of anxiety and depression in persons with epilepsy during the COVID-19 pandemic: A multicountry online survey	46
Risk factors for depression in patients with epilepsy: A meta-analysis	46
Ketogenic diet for infants with epilepsy: A literature review	45
Epilepsy and COVID-19: Updated evidence and narrative review	44
Counseling of people with epilepsy via telemedicine: Experiences at a German tertiary epilepsy center during the COVID-19 pandemic	44
Status epilepticus and COVID-19: A systematic review	42
Depressive symptoms and difficulties in emotion regulation in adult patients with epilepsy: Association with quality of life and stigma	42
The cerebellum and epilepsy	39
GABAergic interneurons in epilepsy: More than a simple change in inhibition	38
Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: A systematic review	37
Intellectual functioning and behavior in Dravet syndrome: A systematic review	36
Brain-responsive corticothalamic stimulation in the centromedian nucleus for the treatment of regional neocortical epilepsy	36
Psychogenic nonepileptic seizures in children—Prospective validation of a clinical care pathway & risk factors for treatment outcome	35

Evaluating risk to people with epilepsy during the COVID-19 pandemic: Preliminary findings from the COV-E study	35
Mechanisms of cognitive impairment in temporal lobe epilepsy: A systematic review of resting-state functional connectivity studies	34
COVID-19 vaccination in patients with epilepsy: First experiences in a German tertiary epilepsy center	34
Influence of the COVID-19 outbreak in people with epilepsy: Analysis of a Spanish population (EPICOVID registry)	34
Seizure clusters, rescue treatments, seizure action plans: Unmet needs and emerging formulations	33
Attitudes and knowledge about cannabis and cannabis-based therapies among US neurologists, nurses, and pharmacists	33
Interictal structural and functional connectivity in idiopathic generalized epilepsy: A systematic review of graph theoretical studies	33
Increased risk of stroke and myocardial infarction in patients with epilepsy: A systematic review of population-based cohort studies	33